Your session is about to expire
← Back to Search
Radiation Therapy
Post-Surgery Radiation Therapy for Head and Neck Cancer
Phase 1 & 2
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 and over
Reirradiation field must overlap the previous field for a minimum of 3 cm in height, width, and length
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is to study if radiation therapy is effective in treating patients with recurrent or second primary cancer of the head and neck who have had previous radiation therapy.
Who is the study for?
This trial is for adults who've had surgery for a recurrent or second primary head and neck cancer after previous radiation. They must have had prior radiation with significant overlap to the current area, be at least 6 months post-prior radiation, and have certain types of squamous cell carcinoma with specific conditions like positive margins or nodes.Check my eligibility
What is being tested?
The study is examining the effectiveness of additional radiation therapy following surgery in patients who previously received radiation for head and neck cancers. It's designed to see if more radiation can help prevent cancer from coming back.See study design
What are the potential side effects?
Potential side effects include damage to skin, subcutaneous tissue, larynx, joints; severe reactions in mucous membranes or bones due to increased exposure to high-energy x-rays on top of previous treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My new radiation treatment area overlaps with the old one by at least 3 cm in all directions.
Select...
I have not experienced severe side effects in my organs.
Select...
I have no cancer history likely to cause death within 3 years.
Select...
I can care for myself but may not be able to do active work.
Select...
My cancer has spread beyond its original location.
Select...
My cancer is a type of squamous cell carcinoma that has come back or is a new cancer in certain areas.
Select...
All visible signs of my cancer were surgically removed.
Select...
It has been over 6 months since my last radiotherapy with a high dose.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,571 Previous Clinical Trials
2,269,411 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,341 Total Patients Enrolled
James L. Pearlman, MDStudy ChairH. Lee Moffitt Cancer Center and Research Institute
2 Previous Clinical Trials
6 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.My cancer has spread to distant parts of my body.My new radiation treatment area overlaps with the old one by at least 3 cm in all directions.I have not experienced severe side effects in my organs.I can provide my previous radiotherapy records.My radiotherapy is scheduled 6-12 weeks after my surgery.I have no cancer history likely to cause death within 3 years.I can care for myself but may not be able to do active work.My cancer has spread beyond its original location.My cancer originated in the upper part of my throat behind the nose.My cancer is a type of squamous cell carcinoma that has come back or is a new cancer in certain areas.All visible signs of my cancer were surgically removed.It has been over 6 months since my last radiotherapy with a high dose.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants being accepted into this clinical trial?
"No, this particular clinical trial is not recruiting patients at the moment. This can be confirmed by checking the posting dates on clinicaltrials.gov; the study was first posted on 5/1/2000 and last updated on 12/3/2013. However, there are 499 other trials which are actively looking for patients right now."
Answered by AI
Share this study with friends
Copy Link
Messenger